Unlock Full Company Report

Access verified contacts, investors & buying signals.

Get Access
Recently Funded|Amount: USD 360.0K|Industry: Medical Device

Histolution GmbH Secures €360K Pre-Seed Funding to Revolutionize Intraoperative Histological Diagnostics with Multi-Photon Microscopy

Histolution GmbH

Histolution GmbH Logo
N/A
2-10 employees employees (Est.)
Visit Website
View Full Report

Includes contacts, investors & buying signals

Histolution GmbH is excited to announce a successful funding round, raising €360,000 to accelerate the development and implementation of its groundbreaking multi-photon microscopy system. This significant investment marks a key milestone for Histolution GmbH, a company at the forefront of medical imaging technology, as it works to transform histological tissue diagnostics in the surgical theatre. With this new capital, Histolution GmbH aims to enhance its state-of-the-art diagnostic platform, designed specifically to provide surgeons with rapid, high-resolution images that unveil the intricate details of tissue structures during operations. The innovative multi-photon microscopy technology promises to revolutionize surgical decision-making, enabling real-time histological assessments that can guide precise interventions, reduce operating times, and ultimately improve patient outcomes. The recent funds will be strategically directed towards further refining the microscope’s imaging capabilities, conducting rigorous clinical trials, and advancing regulatory approvals. Each of these steps is critical as part of Histolution’s broader mission: to integrate cutting-edge optical diagnostics into routine surgical practice, ensuring that critical decisions are backed by the best possible evidence at the moment of care. Furthermore, this funding round not only validates Histolution GmbH’s vision and technological prowess but also reinforces the growing demand for innovative solutions that address critical gaps in surgical diagnostics. As the company embarks on the next phase of its development, the investment stands as a robust vote of confidence from investors and partners alike, strengthening Histolution’s commitment to revolutionize the way surgeons access and utilize histological data during procedures. The future of surgical histopathology is here, and Histolution GmbH is proud to be leading the charge.
April 2, 2025

Buying Signals & Intent

Our AI suggests Histolution GmbH may be interested in solutions related to:

  • Medical Equipment
  • Surgical Instruments
  • Diagnostic Tools
  • Healthcare Technology
  • Research and Development

Sell these products?

Unlock full report to find contacts.

Get Access Now

Investors

Unlock Investor Data

See who invested in Histolution GmbH and potentially find related investment contacts.

Unlock Premium Access

Key Decision Makers

Unlock Verified Contacts

Get direct email addresses and phone numbers for key decision makers at Histolution GmbH.

Unlock Contacts Now